Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Egevad

Showing results (101-110 of 379) with videos related to

Pageof 38
Sort By:
European Urology Focus|July 30, 2017
Balancing Overdiagnosis and Early Detection of Prostate Cancer using the Stockholm-3 ModelTobias Nordström, Henrik Grönberg, Jan Adolfsson, et al.
BJU International|April 21, 2016
Prostate cancer grading: recent developments and future directionsBrett Delahunt, Lars Egevad, David J Grignon, et al.
Scandinavian Journal of Urology and Nephrology|November 1, 2005
The significance of tumor heterogeneity for prediction of DNA ploidy of prostate cancerLars Häggarth, Gert Auer, Christer Busch, et al.
Pathology|November 14, 2014
Optimising pre-analytical factors affecting quality of prostate biopsies: the case for site specific labelling and single core submissionJohn R Srigley, Brett Delahunt, Lars Egevad, et al.
The American Journal of Surgical Pathology|June 21, 2019
Is the UICC/AJCC pT2 Staging Category for Clear Cell Renal Cell Carcinoma Meaningful?Brett Delahunt, Julien Dagher, Lars Egevad, et al.
Pathology|September 5, 2024
Benign prostatic hyperplasia and insignificant prostate cancer with very high levels of serum prostate specific antigenHemamali Samaratunga, Brett Delahunt, Mats Olsson, et al.
The American Journal of Surgical Pathology|April 29, 2020
The International Society of Urological Pathology Consultation on Molecular Pathology of Urogenital CancerTheodorus H van der Kwast, Lars Egevad, Glen Kristiansen, et al.
Virchows Archiv : an International Journal of Pathology|February 4, 2014
Biomarkers in renal cancerHolger Moch, John Srigley, Brett Delahunt, et al.
International Journal of Radiation Oncology, Biology, Physics|January 31, 2012
Castration therapy of prostate cancer results in downregulation of HIF-1α levelsFiras L T Al-Ubaidi, Niklas Schultz, Lars Egevad, et al.
Pathology|April 17, 2019
Percentage grade 4 tumour predicts outcome for clear cell renal cell carcinomaJulien Dagher, Brett Delahunt, Nathalie Rioux-Leclercq, et al.
Pageof 38

Showing results (101-110 of 379) with videos related to

Sort By:
Pageof 38
European Urology Focus|July 30, 2017
Balancing Overdiagnosis and Early Detection of Prostate Cancer using the Stockholm-3 ModelTobias Nordström, Henrik Grönberg, Jan Adolfsson, et al.
BJU International|April 21, 2016
Prostate cancer grading: recent developments and future directionsBrett Delahunt, Lars Egevad, David J Grignon, et al.
Scandinavian Journal of Urology and Nephrology|November 1, 2005
The significance of tumor heterogeneity for prediction of DNA ploidy of prostate cancerLars Häggarth, Gert Auer, Christer Busch, et al.
Pathology|November 14, 2014
Optimising pre-analytical factors affecting quality of prostate biopsies: the case for site specific labelling and single core submissionJohn R Srigley, Brett Delahunt, Lars Egevad, et al.
The American Journal of Surgical Pathology|June 21, 2019
Is the UICC/AJCC pT2 Staging Category for Clear Cell Renal Cell Carcinoma Meaningful?Brett Delahunt, Julien Dagher, Lars Egevad, et al.
Pathology|September 5, 2024
Benign prostatic hyperplasia and insignificant prostate cancer with very high levels of serum prostate specific antigenHemamali Samaratunga, Brett Delahunt, Mats Olsson, et al.
The American Journal of Surgical Pathology|April 29, 2020
The International Society of Urological Pathology Consultation on Molecular Pathology of Urogenital CancerTheodorus H van der Kwast, Lars Egevad, Glen Kristiansen, et al.
Virchows Archiv : an International Journal of Pathology|February 4, 2014
Biomarkers in renal cancerHolger Moch, John Srigley, Brett Delahunt, et al.
International Journal of Radiation Oncology, Biology, Physics|January 31, 2012
Castration therapy of prostate cancer results in downregulation of HIF-1α levelsFiras L T Al-Ubaidi, Niklas Schultz, Lars Egevad, et al.
Pathology|April 17, 2019
Percentage grade 4 tumour predicts outcome for clear cell renal cell carcinomaJulien Dagher, Brett Delahunt, Nathalie Rioux-Leclercq, et al.
Pageof 38